Innovations in cancer drug research

While cancer continues to be one of the leading causes of death and illness, new technology and increasing use of real-world data have the potential to revolutionise care.

The Conference Forum Launches 2017 Clinical Trial Collaborat...

The 2nd annual Clinical Trial Collaborations event

ESMO review: advances in immunotherapy, EMA dialogue and pa...

QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.

Infographic: Solving the challenges of immuno-oncology trial...

The booming interest in new targeted therapies represents a changing of the guard in cancer treatment, from the former one-size-fits-all approach to a more personalised methodology.

Eye on ESMO: Day 2 - gamechangers take centre stage

Novartis’ phase 3 advanced breast cancer therapy ribociclib shows promise

Eye on ESMO 2016